Clinical Trial Update: Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating hepatic artery infusion chemotherapy for unresectable hepatocellular carcinoma after failure of systemic therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Hui-Chuan Sun | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN